PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 19, 2026Renal Failure0 citationsOpen Access

Acute hemodialysis for cancer-associated acute kidney injury: etiologies, indications, and outcomes from a 25-year single-center experience

View Full Paper
AAAydan Mütiş AlanSYSerkan Feyyaz YalınİAİbrahim Ataş

Key Points

  • The aim of this research is to assess the causes, indications, and outcomes of acute kidney injury in cancer patients requiring emergency hemodialysis.
  • Retrospective analysis of cancer patients who underwent emergency hemodialysis for AKI at a tertiary center.
  • Patients categorized by malignancy type: respiratory, hematologic, gastrointestinal, genitourinary, and other.
  • Stratification of data by two time periods: 2000-2010 and 2011-2025.
  • Out of 2,490 hemodialysis patients, 539 (21.6%) had malignancies.
  • Postrenal obstruction was the primary cause of AKI (37%), and uremia was the main reason for needing dialysis (34%).
  • 56% of patients achieved dialysis independence, and renal recovery improved over time.

Abstract

Acute kidney injury (AKI) is a common and life-threatening complication in cancer patients, often leading to treatment interruption and increased mortality. When AKI progresses to the stage requiring hemodialysis, the prognosis becomes particularly poor. This study aimed to evaluate the etiologies, dialysis indications, and outcomes of malignancy-associated AKI requiring emergency hemodialysis over 25 years. This retrospective study included adult patients with malignancies who underwent emergency hemodialysis for AKI at a tertiary referral center between January 2000 and March 2025. Patients were categorized into five malignancy groups-respiratory, hematologic, gastrointestinal, genitourinary, and other-and stratified by two time periods (2000-2010 and 2011-2025), representing the eras of conventional chemotherapy and targeted or immune-based therapies, respectively. Among 2,490 patients who underwent emergency hemodialysis, 539 (21.6%) had malignancies. The median age was 63 years, and 59% of the participants were male. Genitourinary cancers (38%) were the most frequent, followed by hematologic (24%) and gastrointestinal (22%) malignancies. Postrenal obstruction (37%) was the leading etiology of AKI, while uremia (34%) and hyperkalemia (23%) were the main dialysis indications. The median number of dialysis sessions was 4 (range, 1-89), and dialysis independence was achieved in 56% of patients. After 2010, postrenal obstruction and hypercalcemia-related AKI increased, whereas uremia declined, and renal recovery improved significantly. In conclusion, this study provides real-world data on cancer-associated AKI requiring emergency hemodialysis, demonstrating heterogeneity in etiologies and dialysis indications across malignancy types. Temporal improvements in renal recovery suggest better kidney outcomes over time, emphasizing the need for optimized management and multidisciplinary care.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Alan et al. (2026) studied this question.

synapsesocial.com/papers/69e4713b010ef96374d8dc84https://doi.org/10.1080/0886022x.2026.2651473
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Acute Kidney Injury in Hospitalized Cancer Patients: Single-Centre Real-Life Analysis of Incidence and Clinical Impact2026 · 2 citations
  2. 2Pharmacological nephrotoxicity profile in a comprehensive cancer center: What changed in two decades and predictors for the need for haemodialysis and mortality2025
  3. 3Clinical Characteristics, Outcomes, and Prognosis among Cancer Patients with Acute Kidney Injury: A Single-Center Study at Sohag Cancer Center2024
  4. 4WCN24-2373 SEVERE ACUTE KIDNEY INJURY IN CANCER PATIENTS OVER THE LAST 20 YEARS IN A COMPREHENSIVE CANCER CENTER2024
  5. 5Renal Involvement in Cancer Patients Undergoing Oncology Therapies: Implications for Personalized Treatment Strategies2026